US Bancorp’s Akcea Therapeutics Inc AKCA Stock Holding History

US Bancorp’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-150	Closed	-$3K	–	3966
2020 Q3	$3K	Buy	+150	New	+$2.13K	﹤0.01%	3466

US Bancorp's AKCA Position: Q4 2020 in Review

US Bancorp sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 150 shares — an estimated $3K sold.

US Bancorp first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

US Bancorp reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
US Bancorp sold 150 Akcea Therapeutics Inc shares in Q4 2020, an estimated $3K.
US Bancorp first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
US Bancorp's Akcea Therapeutics Inc position peaked at $3K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.